Dr. Tracy Lynne Skaer

Department of Pharmacotherapy, College of Pharmacy

Washington State University Health Sciences

Email: tskaer@wsu.edu

Qualifications

2007 UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL - Graduate Certificate, Center for Mindfulness in Medicine, Health Care, and Society – Sabbatical Leave, Summer Intensive Practicum, in Mindfulness-Based Stress Reduction

2001 UNIVERSITY OF SOUTH CAROLINA -Graduate Certificate, Financial Management, Moore Graduate School of Business

2000 UNIVERSITY OF CALIFORNIA AT LOS ANGELES - Graduate Certificate, Women's Leadership Institute, Anderson Graduate School of Business

1998 CORNELL UNIVERSITY - Graduate Certificate, Administrative Management Institute for Higher Education, Johnson Graduate School of Business

1990 UNIVERSITY OF SOUTHERN CALIFORNIA - Doctor of Pharmacy (Summa Cum Laude)

1985 WASHINGTON STATE UNIVERSITY - Bachelor of Pharmacy

1982 SPOKANE FALLS COMMUNITY COLLEGE - Associate of Arts

Publications (selected)

1. Sclar DA, Skaer TL, Robison LM, Galin RS. Economic Appraisal of Citalopram in the Management of Single-Episode Depression.Journal of Clinical Psychopharmacology. 1999; 19(Suppl 1): 47S-54S. [Cited 19 times]
2. Skaer TL, Robison LM, Sclar DA, Galin RS. Treatment of Depressive Illness Among Children and Adolescents in the United States.Current Therapeutic Research. 2000; 61(10): 692-705. [Cited 7 times]
3. Skaer TL, Robison LM, Sclar DA, Galin RS. Anxiety Disorders in the USA, 1990 to 1997: Trend in Complaint, Diagnosis, Use of Pharmacotherapy, and Diagnosis of Comorbid Depression.Clinical Drug Investigation. 2000; 20(4): 255-265. [Cited 18 times]
4. Ballasiotes AA, Skaer TL. Use of Lamotrigine in a Patient with Bipolar Disorder and Psychiatric Comorbidity.Clinical Therapeutics. 2000; 22(9): 1146-1148. [Cited 6 times]
5. Skaer TL, Sclar DA, Robison LM, Galin RS. Trend in the Use of Antidepressant Pharmacotherapy and Diagnosis of Depression in the USA: An Assessment of Office-Based Visits 1990 to 1998.CNS Drugs. 2000; 14(6): 473-481. [Cited 21 times]
6. Skaer TL, Sclar DA, Robison LM, Galin RS. Trends in the Rate of Depressive Illness and Use of Antidepressive Pharmacotherapy by Ethnicity / Race. An Assessment of Office-Based Visits in the United States, 1992-1997.Clinical Therapeutics. 2000; 22(12): 1575-1589. [Cited 80 times]
7. Skaer TL, Sclar DA, Robison LM, Galin RS. Trends in the Rate of Self-Report and Diagnosis of Erectile Dysfunction in the United States 1990-1998. Was the Introduction of Sildenafil an Influencing Factor?Disease Management & Health Outcomes. 2001; 9(1): 33-41. [Cited 8 times]
8. Skaer TL, Sclar DA, Robison LM. Complaint of Insomnia in the United States 1995-1998: Prevalence, Psychiatric Comorbidity, and Pharmacologic Treatment Patterns.Primary Care Psychiatry. 2001; 7(4): 145-151. [Cited 8 times]
9. Skaer TL, Sclar DA, Evans MA, Mukherjee SK, Robison LM. HMG-CoA Reductase Inhibitors in Secondary Prevention of Coronary Heart Disease: Comparison of Expense per Year of Life Gained.American Journal of Cardiology. 2001; 87(Suppl R): 21-25.
10. Robison LM, Skaer TL, Sclar DA, Galin RS. Is Attention-Deficit / Hyperactivity Disorder Increasing Among Girls in the U.S.? Trends in Diagnosis and the Prescribing of Stimulants. CNS Drugs. 2002; 16(2): 129-137. [Cited 131 times]
11. Robison LM, Sclar DA, Skaer TL, Galin RS. Treatment Modalities Among U.S. Children Diagnosed with Attention-Deficit/Hyperactivity Disorder: 1995 - 1999.International Clinical Psychopharmacology. 2004; 19(1): 17-22. [Cited 33 times]
12. Skaer TL, Sclar DA, Robison LM. Antidepressant Trends Among Children and Adolescents Diagnosed with Depression: 1990-2001.Journal of Child and Adolescent Psychopharmacology. 2004; 14(4): 528-529. [Cited 3 times]
13. Robison LM, Skaer TL, Sclar DA. Is Attention-Deficit Hyperactivity Disorder Diagnosed in Adults? An Examination of U.S. Office-Based Physician Visits, 1995-2000.International Journal of Pharmaceutical Medicine. 2004; 18(6): 337-341. [Cited 5 times]
14. Robison LM, Sclar DA, Skaer TL. Datapoints: Trends in ADHD and Stimulant Use among U.S. Adults: 1995-2002. Psychiatric Services. 2005; 56(12): 1497. [Cited 21 times]
15. Sclar DA, Evans MA, Skaer TL, Robison LM, Chung KC, Poulios NS. Economic and Epidemiologic Modeling of Full-Length Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM), in Previously Treated Patients with Hemophilia A. Comparison with B-Domain Deleted rFVIII (BDDrFVIII), and Utility of Potential Viral Transmission Reduction Due to Plasma/Albumin-Free Status. Drugs in Research and Development. 2005; 6(3): 149-156. [Cited 3 times]
16. Sclar DA, Evans MA, White JR, Skaer TL, Robison LM. Economics of basal insulin added to oral agents versus twice-daily premised insulin as initial therapy for type 2 diabetes. Dibetologia. 2005; 48: A335. [Cited 3 times]
17. Skaer TL, Sclar DA, Robison LM. Trends in the Prescribing of Oral Agents for the Management of Type 2 Diabetes Mellitus in the United States 1990-2001. Does Type of Insurance Influence Access to Innovation?Diabetes Educator. 2006; 32(6): 940-953. [Cited 8 times]
18. Cloutier S, Skaer TL, Newberry RC. Consumption of Alcohol by Sows in a Choice Test. Physiology and Behavior. 2006; 88: 101-107. [Cited 4 times]
19. Fournier LR, Ryan-Borchers TA, Robison LM, Wiediger MA, Park JS, Chew BP, McGuire MK, Sclar DA, Skaer TL, Beerman KA. The Effects of Soy Milk and Soy Isoflavone Supplements on Cognitive Performance in Healthy Postmenopausal Women. Journal of Nutrition Health and Aging. 2007; 11(2): 155-164. [Cited 62 times]
20. Sclar DA, Robison LM, Skaer TL. Concomitant Triptan and SSRI or SNRI Use: A Risk for Serotonin Syndrome. Headache: The Journal of Head and Face Pain. 2008; 48(1): 126-129. [Cited 21 times]